Clinical
Search
Sign Up
To keep up to date with all our latest news, events and products,why not sign up to our newsletter.
Sign up now >
Sign up now >
An online educational resource with continuously updated information on serum free light chain and Hevylite® analysis.
25
Patient Management Stage
International Myeloma Working Group guidelines for serum-free light chain analysis in Multiple Myeloma and related disorders1 recommend the use of Freelite® at 3 key stages of patient management.
- Recommended for the use of the serum FLC assay in screening
- Recommended for the use of the serum FLC assay in prognosis
- Recommended for the use of the serum FLC assay in response assessment
The advice in these guidelines was based upon results obtained in extensive clinical trials using the polyclonal Freelite® assays.
References
References- Dispenzieri, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009; 23:215-224 Request your copy - code MKG514
